Oxford Nanopore Raises $217M

Oxford Nanopore raised $217M in a recent funding round to further develop its genetic sequencing technology. The UK-based company offers sequencing technology capable of analyzing a single DNA or RNA molecule at a time while providing data in real time.

There are many applications for nanopore technology from clinical to biological research. Most recently, OxFord Nanopore developed a rapid diagnostic test for COVID-19.

Derek Stein (Physics) has a long standing relationship with Oxford Nanopore leading to sponsored work in product development. Full story here.